• Health & Medicine

Immunotherapy improves survival for people with aggressive, asbestos-linked lung cancer

People with an aggressive form of lung cancer that’s come back after treatment could live longer when treated with the immunotherapy drug nivolumab. People with an aggressive form of lung cancer that’s come back after treatment could live longer when treated with the immunotherapy drug nivolumab.

30 January 2021

• Health & Medicine
• Policy & Insight

Opinion: 'Beating cancer means beating it for everyone'

We’ve long felt that Cancer Research UK has a role to play in tackling inequalities, writes Michelle Mitchell. We’ve long felt that Cancer Research UK has a role to play in tackling inequalities, writes Michelle Mitchell.

29 January 2021

• Charity News

Cancer Research UK launches its new equality, diversity and inclusion strategy

Cancer Research UK has today launched its first charity-wide Equality, Diversity and Inclusion strategy, outlining the charity’s commitments to improve progress Cancer Research UK has today launched its first charity-wide Equality, Diversity and Inclusion strategy, outlining the charity’s commitments to improve progress

29 January 2021

• For Researchers

2021: A bright future for cancer research

Despite a difficult 2020, there is a lot to be excited about for cancer research in 2021. Three experts tell us how progress is changing the research landscape. Despite a difficult 2020, there is a lot to be excited about for cancer research in 2021. Three experts tell us how progress is changing the research landscape.

28 January 2021

• Health & Medicine

Transforming optimism: finding new ways to treat rare cancers

We spoke to Dr Kate Cwynarski, who led the Stand Up To Cancer-funded MARIETTA trial, a clinical trial which details a “potentially transforming” treatment for some patients with secondary CNS lymphoma. We spoke to Dr Kate Cwynarski, who led the Stand Up To Cancer-funded MARIETTA trial, a clinical trial which details a “potentially transforming” treatment for some patients with secondary CNS lymphoma.

27 January 2021

• Science & Technology
• Health & Medicine

Genetic changes in tumours may predict who will respond to immunotherapy

Genetic changes in tumours could be used to predict who will benefit from immunotherapy, and who should receive other treatments.  Genetic changes in tumours could be used to predict who will benefit from immunotherapy, and who should receive other treatments. 

27 January 2021

• Charity News

Cancer Research UK appoints new executive director of Policy, Information and Communications

The world’s leading cancer charity, Cancer Research UK, has appointed Ian Walker as its executive director of Policy, Information and Communications. The world’s leading cancer charity, Cancer Research UK, has appointed Ian Walker as its executive director of Policy, Information and Communications.

27 January 2021

• Health & Medicine

NHS COVID-19 vaccination centre opens at London’s Francis Crick Institute

The Francis Crick Institute – of which Cancer Research UK is a major funder – has partnered with UCLH to establish a COVID-19 vaccination centre. The Francis Crick Institute – of which Cancer Research UK is a major funder – has partnered with UCLH to establish a COVID-19 vaccination centre.

22 January 2021

• Health & Medicine

Three new cancer drugs approved for NHS in Scotland

The three latest SMC decisions will provide new treatment options for some adults with non small cell lung cancer, multiple myeloma and a rare type of lymphoma. The three latest SMC decisions will provide new treatment options for some adults with non small cell lung cancer, multiple myeloma and a rare type of lymphoma.

21 January 2021

• Health & Medicine

NHS patients among first to access new CAR T cell therapy for lymphoma

Lymphoma patients in England are among the first in the world to be offered new CAR T cell therapy. Lymphoma patients in England are among the first in the world to be offered new CAR T cell therapy.

20 January 2021

• Health & Medicine

NICE approves new maintenance treatment for ovarian cancer

A new targeted treatment has been recommended by the National Institute of Health and Care Excellence for some adults with ovarian cancer. A new targeted treatment has been recommended by the National Institute of Health and Care Excellence for some adults with ovarian cancer.

19 January 2021

• Science & Technology
• Health & Medicine

Discovering the BRCA2 gene – 25 years on

25 years ago, a team of our scientists were celebrating. Their risky strategy had paid off. 25 years ago, a team of our scientists were celebrating. Their risky strategy had paid off.

14 January 2021